After eight years of research, a new breakthrough in science has taken a big step forward in potentially stopping the transmission of Lyme disease between mice and ticks.
Earlier this month, Care Access said the FDA inspected the company’s activities in the Lyme vaccine trials and it resulted in no “Form 483,” observations, meaning investigators found no clinical practices violations.
A first of its kind Lyme disease vaccine trial ran into a road block last weekend as the developers announced they had discontinued the study for about half of the thousands of participants in the U.S. — including those on Martha’s Vineyard.
Organizers of a first-of-its-kind Lyme disease vaccine trial on Martha’s Vineyard are still looking for signups, after an initial wave of recruitment has slowed down in recent months.
Just as medical professionals on the Vineyard are feeling encouraged by the start of a Lyme vaccine trial, Island doctors are reporting numerous instances of itchy, painful rashes caused by lone star tick larvae in so-called “tick bombs.”
Statistically home to one of the highest percentages of tick-borne illnesses in the world, Martha’s Vineyard will soon be the setting for a clinical trial of a vaccine aimed at preventing Lyme disease.
As a particularly pervasive summer for ticks on the Island winds down, the Infectious Disease Society of America has released new draft guidelines for the prevention, diagnosis and treatment of Lyme disease.
Island hunters took nearly 800 deer during the 2017 deer hunting season, the highest harvest in at least 16 years, according to recently released state data.
Shotgun hunting season began Monday, and the weigh station was busy this week with hunters, biologists collecting ticks, and a new deer donation program.
